Import price of sparsentan/sparsentan in 2025

Sparsentan is a new drug used to treat primary immunoglobulin A nephropathy (IgAN), a disease that affects the kidneys. IgAN is a chronic glomerular inflammation characterized by the deposition of immunoglobulin A, which often leads to a gradual decline in renal function and may eventually develop into end-stage renal disease. The disease usually first manifests in adolescence or young adults, and patients may experience symptoms such as hematuria and proteinuria. In severe cases, it can cause high blood pressure and renal failure.

Sparsentan works through a dual mechanism. It is not only a selective angiotensin II receptor antagonist (ARB), but also has renin-inhibiting properties. This unique mechanism allows sparsentane to effectively reduce the pressure within the renal tubules and reduce glomerular damage, thereby slowing the progression of renal function. Clinical trial results show that sparsentan can significantly reduce urinary protein levels, which is of great significance for the evaluation and management of IgAN patients.

Compared with traditional treatments, sparsentane has shown good effects in controlling disease progression and protecting renal function, and it is relatively well tolerated. Sparsentan offers a new treatment option for patients who have failed to respond or experience side effects from other treatments.

As for the imported price of the drug, the original drug of sparsentan has not yet been launched in China, and the specific price has yet to be confirmed. The drug has been on the overseas market for a short time. The common specifications are 200mg and 400mg. Each box contains 30 tablets. The European version may be sold for more than 40,000 yuan, depending on exchange rate fluctuations. In addition, there are also generic drugs of sparsentan on the market, and their drug ingredients are consistent with the original version. For example, the 400mg version produced by a pharmaceutical factory in Laos costs about 7,000 yuan per box of 30 tablets (also affected by the exchange rate).

Reference materials:https://go.drugbank.com/drugs/DB12548